Page last updated: 2024-09-04

arginylproline and Genetic Predisposition

arginylproline has been researched along with Genetic Predisposition in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdelgader, EA; Abdelrahim, SO; Altayeb, OA; Babekir, EA; Eltayeb, NH; Fadul, EA; Ibrahim, IK; Mohammed Basabaeen, AA; Sabo, A1
Duan, YZ; Jiang, N; Pan, J; Wang, L1

Reviews

1 review(s) available for arginylproline and Genetic Predisposition

ArticleYear
No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2013, Volume: 34, Issue:1

    Topics: Asian People; Codon; Confidence Intervals; Dipeptides; Genes, p53; Genetic Predisposition to Disease; Humans; Mouth Neoplasms; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors; Tumor Suppressor Protein p53; White People

2013

Other Studies

1 other study(ies) available for arginylproline and Genetic Predisposition

ArticleYear
TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population
    Asian Pacific journal of cancer prevention : APJCP, 2019, May-25, Volume: 20, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Case-Control Studies; Codon; Dipeptides; Female; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Polymorphism, Single Nucleotide; Sudan; Tumor Suppressor Protein p53; Young Adult

2019